Milena S. Espíndola

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF”.

Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF

JCI Insight(2021)10.1172/jci.insight.141061

N/A

0DataRank · unranked

25 citations

David M. Habiel, Milena S. Espíndola, Guanling Huang, Isabelle Jones, Rohan Narayanan +17 more

Potential mechanisms for lung fibrosis associated with COVID-19 infection

QJM(2022)10.1093/qjmed/hcac206

N/A

0DataRank · unranked

31 citations

Milena S. Espíndola, Alberto M. Marchevsky, R. Rampolla, Peter Chen, Cory M. Hogaboam +1 more

Maladaptive TGF-β Signals to the Alveolar Epithelium Drive Fibrosis after COVID-19 Infection

American Journal of Respiratory and Critical Care Medicine(2023)10.1164/rccm.202302-0264le

N/A

0DataRank · unranked

23 citations

Tanyalak Parimon, Milena S. Espíndola, M. Hohmann, Bindu Konda, Cory M. Hogaboam +3 more

Immune mechanisms in fibrotic interstitial lung disease

Cell(2024)10.1016/j.cell.2024.05.015

N/A

0DataRank · unranked

101 citations

Hannah M. Carter, Milena S. Espíndola, Tracy J. Doyle, Joyce Lee, Louis T. Merriam +8 more

Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.24.589970

N/A

0DataRank · unranked

2 citations

Poornima Mahavadi, Yago Amigo Pinho Jannini de Sá, Brecht Creyns, Ana Lúcia Coelho, Milena S. Espíndola +5 more